Labcorp Acquires BioReference Health’s Oncology Testing Assets for $225 Million
The deal includes customer accounts and operating assets focused on cancer-related clinical testing services across the United States.
Latest Articles
Editor's Top Picks
Clinical Labs Navigate What’s Next After FDA’s LDT Rule Reversal
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Global Trial for Blood-Based Hematology Diagnostics to Launch
Three-year PERIBLOOD study will evaluate single-cell RNA sequencing as minimally invasive alternative to bone marrow aspiration for blood disorder diagnosis.
Equipment & Supply Spotlight
Multitiered Business Intelligence Platform for Lab Data Analytics Launches
The new platform offers three-tiered approach to help laboratories at different stages of data maturity extract actionable insights from operational data.
News, Know-How & Standards
Disease Detection & Understanding
Circulating Tumor DNA Shows Promise for Guiding Immunotherapy in Lung Cancer
Study of 177 patients with limited-stage small cell lung cancer demonstrates ctDNA's potential to personalize consolidation immunotherapy decisions.
